Jobs
View more job listings or post a job
PPD, Inc. Scientist-HPLC, GC          
Escient Pharmaceuticals Scientist - DMPK  
GNF (Novartis) Scientific Associate II
ChemoCentryx Inc. Senior Research Associate to Scientist I, DMPK
Precision for Medicine Senior Scientific Director, Bioanalytical Sciences
Precision for Medicine Scientist - Flow Cytometry
Precision for Medicine Senior Research Associate
Maze Therapeutics Research Associate, DMPK, Drug Discovery
Gilead Sciences Senior Research Associate, Drug Metabolism
Post a job

Symposium

Advances in Immuno-Oncology (A Joint Symposium by PBSS and BioScience Forum)


Speakers: Alex Franzusoff (PACT Pharma), David Kirn (4D Molecular Therapeutics), Wei Lin (Nektar), Fred Ramsdell (Parker Institute), Terri McClanahan (Merck), Stephen Becker (Bryologyx), Hong Jin (Medimmune), Mary J. Janatpour (Dynavax) & More...
Organizers:
Date: 6/11/2019
Time: 8:45-17:00
Registration fee (USD): Regular: $195; Academic: $125; Students & Unemployed: $35; Major Sponsor's Rep (incl lunch): $0;
Location: Crowne Plaza, Foster City, CA
Major Sponsor: (3)Applied BioMath, LLC; KCAS Bioanalytical & Biomarker Services; PerkinElmer;(Sponsorship - Reception still open)
Vendor show vendors registered to date: (13)Applied StemCell; Aragen Bioscience; BioDuro; Charles River Labs; Intertek; Lonza; Novogene Corporation; PeproTech Inc; PHC former Panasonic Healthcare; R&D Systems; SEKISUI XenoTech; Viracor Eurofins; WuXi Apptec
Registration: http://www.PBSS.org
Registration deadline:6/11/2019  (it will close sooner if the seating cap is reached)

About the Topic

The last few years has seen major advancements in cancer treatment through immunotherapy. This symposium aims to provide a comprehensive overview of the emerging concepts in cancer immunotherapy from the latest biologic insights in academia and the latest clinical data for approved and investigational immuno-oncology agents from key biotech and pharmaceutical companies. We will discuss the latest partnership trends and business development efforts in this rapidly evolving landscape.

Tentative topics include:

-oncolytic viruses
-CAR-T therapy
-TGFbeta and the tumor microenvironment
-neoantigens cancer vaccines
-TCR therapy
-novel combinations with checkpoint inhibitors


About the Speakers

Speakers:

-Alex Franzusoff, CEO, PACT Pharma
-Wei Lin, MD, SVP Clinical Development, Nektar
-Fred Ramsdell, Chief Scientific Officer, Parker Institute
-Terri McClanahan, Executive Director, Merck
-Stephen Becker, Chief Medical Officer, Bryologyx
-Juan Jaen, President, Arcus
-Jane Grogan, Principal Scientist, Genentech
-Hong Jin, Senior Director/Fellow, Medimmune / AstraZeneca 
-Mary J. Janatpour, VP Oncology Research, Dynavax
-Speaker TBD, Iovance

More speakers will be confirmed shortly...Agenda coming soon...So stay tuned. If you wish to recommend a speaker, please contact info@pbss.org


2019-04-25, Tox 21 and New Approach Methodology (NAMs): Using Emerging Technologies to Improve Translational Research and Safety Assessment Predictions (jointly by SOT-NorCal & PBSS)
2019-05-06, CMC Development for Biologics: Purification, Formulation, Analytical Characterization, Production Systems, Regulatory and Product Development
2019-07-26, Advances in Enzyme Engineering (tentative)
2019-09-13, Biotransformation and Disposition of Larger Molecules: Peptides, Nucleotides, Proteins, mAbs, and ADCs
2019-10-03, Small-Molecule Bioanalytical Method Validation & Regulated Bioanalysis: Fundamentals, the New FDA Guidance and Regulatory Trends
2019-10-18, Physiologically Based Pharmacokinetic (PBPK) Modeling: Fundamentals, Regulatory Guidance & Applications
┬ęPharmaceutical & BioScience Society, International; Last Modified: 4/23/2019; Visited: 50; Admin Logon
Ads (in random order)
Submit a Text Ad
($200 for 2 months)

Immunomind Scientific Consulting - Protocol Development, Data Analysis, Lab Guidance, Tech Transfer - Meeting your project goals at a moment's notice.
Hypha Discovery mg-g scale synthesis/purification of CYP/non-CYP metabolites including glucuronides. Plus NEW PolyCYPs kits for in-house synthesis of CYP metabolites.
MicroConstants MicroConstants is a GLP-compliant Contract Research Organization focused on performing regulated bioanalysis, drug metabolism and PK analysis.
Viva Biotech World Leading CRO in Structural Biol. & Protein Sci.; Med. Chemistry; ASMS Screening; SPR; Fab/ant X-cryst; In Vitro Pharmacology; mAb discovery; GPCR
Analiza PhysChem & ADME Analytical Services -Solubility, LogD/P, pKa, PAMPA, Metabolic Stability, Cyp 450 & More. FAST, FLEXIBLE, ACCURATE, AND AFFORDABLE!
Submit a Text Ad